Home 
Blogs Chief Editor Rob Wright Feature
Blogs Chief Editor Rob Wright Feature
The current trend toward green living and utilizing “earth-friendly goods” continues to rise. Green manufacturing has become so popular that there is even Green Manufacturing…
Crowdsourcing Pharma Drug Development
Written by Cliff Mintz
Thinning drug pipelines, burgeoning development costs, and a lack of innovation suggest that the traditional pharmaceutical drug development process is too costly and inefficient to…
To bolster its therapeutic MAb (monoclonal antibody) development pipeline, in 2006, AstraZeneca purchased United Kingdom-based Cambridge Antibody Technology, and shortly thereafter, in 2007, acquired MedImmune…
Editorial Board Blogs
-
Bringing Biotech to Boats at BIO World Congress
Bringing Biotech to Boats at BIO World Congress
At the 2013 BIO World Congress on Industrial Biotechnology in Montreal next month you’ll be able to see a Campion boat on the exhibit show floor. “What will a boat be doing on the show floor of an industrial biotech[…]
Source: BIOtechNow
-
Leadership Lesson: The Difference Between Google and Apple
Leadership Lesson: The Difference Between Google and Apple
Google and Apple are both highly esteemed brands. Both companies share many common traits which have contributed to their success, but there is one very big difference between the two – Google plays offense while Apple has recently settled for[…]
Source: N2Growth Blog
-
Only 12% of Public Biotechs are Profitable
Only 12% of Public Biotechs are Profitable
Of the 286 biotech companies trading on public exchanges today, 241 focus on drug development, a slight drop in numbers from last year.* Of these 241 in the biopharmaceutical space, only 28 (12%) had both a product on the market[…]
Source: BIOtechNow
-
The Conundrum Of Healthcare In India
The Conundrum Of Healthcare In India
On a daily basis, one can come across a story in the U.S. print or electronic media about the problems faced in this country around the increased number of overweight and obese Americans. These concerns are justified. Obesity is the[…]
Source: Drug Truths
-
The FDA Approval Of Merck’s Cholesterol Lowerer, Liptruzet, Doesn’t Help Its Credibility
The FDA Approval Of Merck’s Cholesterol Lowerer, Liptruzet, Doesn’t Help Its Credibility
Josh Bloom recently wrote a very provocative piece entitled: “How can Merck look itself in the mirror?” Bloom is concerned that this once greatly admired pharmaceutical company has lost its way by bringing to market the LDL cholesterol lowering drug,[…]
Source: Drug Truths
-
Careering around in Cheltenham!
Careering around in Cheltenham!
Careering around in Cheltenham! By Katrina Brockbank Last month I attended the Cheltenham Festivals “Careering Around” careers fair. Run by STEMNET (Science, Technology, Engineering and Mathematics network) the careers fair aimed to introduce young people to the professional opportunities that[…]
Source: Freeman Technology - Free Flow
-
How To Predict The Future
How To Predict The Future
By Mike Myatt, Chief Strategy Officer, N2growth
Life is just plain easier when you can see what’s ahead of you. Some leaders clearly have poor vision – their most polished skill seems to be running into brick walls. Other leaders[…]
Source: N2Growth Blog
-
The missing link?
The missing link?
The missing link? By Tim Freeman I recently attended the Arden House Conference (48th AAPS Annual Arden House Conference) which this year was focusing on advances in pharmaceutical material characterisation and their importance in the effective application of QbD. There[…]
Source: Freeman Technology - Free Flow
By A Web Design
